精华制药：8月28日召开董事会会议

Group 1 - The company Jinghua Pharmaceutical (SZ 002349) announced on August 30 that its sixth board meeting was held on August 28, 2025, to review the proposal for the reappointment of the accounting firm [1] - For the first half of 2025, the company's revenue composition was entirely from the pharmaceutical industry, with a 100.0% share [1]